Lessons Learned from Pediatric COVID-19 Vaccine Roll-outs that May Inform Future Efforts
With the recent authorization and recommendation of vaccines for use in children ages 6 months through 4 years, the nation’s public health programs are looking to understand the lessons of the vaccine roll-out for 5-11-year-olds and find innovative approaches to improving vaccination coverage of these and younger children. To gather these lessons learned, prior to the availability of COVID-19 vaccines for children <5 years, immunization program (IP) managers (sometimes in addition to other key jurisdiction staff) from the 64 CDC-funded state, city, and territorial programs were invited to participate in a series of four facilitated listening sessions conducted by AIM. In these sessions, lessons learned from the pediatric COVID-19 vaccine roll-out for children ages 5-11 were shared. A final summary session included CDC staff providing responses and input.